Lucy Yang
- Safety and pharmacology of a soluble epoxide hydrolase inhibitorBy Aili Lazaar, Lucy Yang, Jon Robertson, Navin Goyal, Rebecca Boardley, Ruth Tal-Singer, Joseph Cheriyan, David Newby, Ian Wilkinson and Ruth MayerAili Lazaar1Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, United StatesLucy Yang2Department of Medicine, Addenbrooke's Hospital, Cambridge, United KingdomJon Robertson3Clinical Statistics, GlaxoSmithKline, Stevenage, United KingdomNavin Goyal4Clinical Pharmacology, Modeling and Simulation, GlaxoSmithKline, King of Prussia, United StatesRebecca Boardley5Clinical Pharmacology Science & Study Operations, GlaxoSmithKline, Stevenage, United KingdomRuth Tal-Singer1Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, United StatesJoseph Cheriyan2Department of Medicine, Addenbrooke's Hospital, Cambridge, United KingdomDavid Newby6Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United KingdomIan Wilkinson2Department of Medicine, Addenbrooke's Hospital, Cambridge, United KingdomRuth Mayer1Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.